Four Decades for Justice
Cravath represented Compagnie de Saint‑Gobain as U.S. counsel in connection with the placement, through its subsidiary Schenker‑Winkler Holding AG, of approximately 15.2 million of Sika shares, representing its full stake of 10.75% in Sika, for a total of CHF 2.56 billion. The Sika shares were placed via an accelerated book‑building process. Compagnie de Saint‑Gobain designs, manufactures, and distributes materials and solutions for wellbeing worldwide. The Sika shares are listed on the SIX Swiss Exchange Ltd. The transaction closed on May 29, 2020.
The Cravath team included partner George A. Stephanakis and associate Henri R. Simonet.
Deals & Cases
February 05, 2024
Cravath represented Artivion, Inc. in connection with $350 million of credit facilities obtained from Ares Management Credit funds to comprehensively address its debt maturities. Artivion is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons’ most difficult challenges in treating patients with aortic diseases. The facilities consisted of a $190 million secured term loan facility, a $100 million secured delayed draw term loan facility and a $60 million secured revolving credit facility. The transaction closed on January 18, 2024.
Deals & Cases
February 01, 2023
Cravath represented Monogram Health Holdings, Inc. in connection with its $375 million Series C financing round, consisting of a private placement of series C preferred stock. Monogram Health Holdings is the parent company of Monogram Health, Inc., a leading kidney‑disease‑focused benefit management and care delivery company. The transaction closed on December 23, 2022.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.